These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 97826)

  • 1. Quantitative approaches to the assessment of cell-mediated immune responses to solid tumor allografts.
    MacDonald HR; Lees RK; Howell RL
    Transplant Proc; 1978 Jun; 10(2):339-42. PubMed ID: 97826
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effect of X irradiation and cell-mediated immune reaction.
    Song CW; Guertin DP
    Radiat Res; 1978 Sep; 75(3):586-92. PubMed ID: 103127
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of anti-tumor antibody in progressive tumor growth.
    Manson LA
    Transplant Proc; 1984 Apr; 16(2):524-7. PubMed ID: 6426105
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 6. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice.
    Lord EM; Nardella G
    Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte mediated lysis of tumor cells in the presence of alloantiserum.
    Liepins A; Faanes RB; Choi YS; de Harven E
    Cell Immunol; 1978 Mar; 36(2):331-44. PubMed ID: 415815
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous immune rejection of intraocular tumors in mice.
    Niederkorn JY; Meunier PC
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant immunization by the fully antigenic counterparts prevents modulated tumor cells from escaping cellular immune elimination.
    De Boer RJ; Michelson S; Hogeweg P
    J Immunol; 1986 Jun; 136(11):4319-27. PubMed ID: 2939142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic antibodies and lymphocytes induced by orthotopic tooth bud allografts in mice.
    Riviere GR
    J Immunol; 1974 Feb; 112(2):776-82. PubMed ID: 4205208
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 15. Reconsidering the immunologic privilege and lymphatic drainage of the anterior chamber of the eye.
    Niederkorn JY; Lynch MG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):259-60. PubMed ID: 2495604
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro induction of cell-mediated cytotoxicity].
    Lohmann-Matthes M-L
    Allerg Immunol (Leipz); 1973; 19(2-4):297-302. PubMed ID: 4281631
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 19. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.